More News Highlights
Whistleblowers Prompt Settlement In Foreclosure Abuse Cases
Washington, D.C. February 9, 2010. The United States government and numerous state governments reached a settlement agreement with five major banks to resolve lawsuits and investigations concerning foreclosure-abuses that fueled the financial "meltdown" and forced millions of Americans out of their homes. Read More
U.S. Government Continues to Collect Billions from Tax Whistleblower Disclosures
U.S. Treasurer has collected over $5 billion based on the whistleblowing of former UBS Swiss banker Bradley Birkenfeld. The most recent collections can be viewed here.
FBI Media Campaign Improperly Ignores Whistleblower Reward Programs
March 1, 2012 - The FBI has cast Hollywood actor Michael Douglas in a new Public Service Announcement asking whistleblowers to report financial fraud to the FBI. However, the FBI’s ad campaign leaves out some key information as the FBI tries to attract tips from whistleblowers about corporate and financial fraud.
KKC partner David K. Colapinto told the Washington Post if whistleblowers “just go to the FBI, they are probably going to get zero. The FBI’s not obligated to do anything for them.”
Whistleblowers Expose FDA’s Illegal Surveillance of Employees
Six FDA Whistleblowers File Complaint in U.S. District Court Seeking Injunction
Washington, D.C. January 30, 2012. As reported in today's Washington Post, six current and former employees of the Food and Drug Administration (FDA) have filed a complaint against the FDA in U.S. District Court. The employees are seeking an injunction to stop the agency from illegally spying on employees’ private communications to Congress and other oversight agencies.
- Office of Special Counsel Opens Investigation into FDA’s Surveillance of Employees’ E-mail.
- Representative Darrell Issa, launched an investigation into the FDA's targeting of whistleblowers for highly intrusive monitoring and computerized searches.
- Senator Charles E. Grassley (R-Iowa) launched an investigation in response to the lawsuit filed by six FDA whistleblowers.
- New York Times Editorial: Pursuit of the Whistle-Blowers